Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 291.40
-5.90 (-1.98%)
Jul 21, 2026, 11:09 AM CET
Zealand Pharma Revenue
Zealand Pharma had revenue of 34.00M DKK in the quarter ending March 31, 2026, with 325.00% growth. This brings the company's revenue in the last twelve months to 9.24B, up 16,519.49% year-over-year. In the year 2025, Zealand Pharma had annual revenue of 9.21B with 14,598.86% growth.
Revenue (ttm)
9.24B
Revenue Growth
+16,519.49%
P/S Ratio
2.26
Revenue / Employee
16.99M
Employees
544
Market Cap
20.88B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.21B | 9.15B | 14,598.86% |
| Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
| Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
| Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
| Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
| Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
| Dec 31, 2019 | 41.33M | 3.36M | 8.84% |
| Dec 31, 2018 | 37.98M | -98.35M | -72.14% |
| Dec 31, 2017 | 136.32M | -94.54M | -40.95% |
| Dec 31, 2016 | 230.86M | 43.19M | 23.01% |
| Dec 31, 2015 | 187.68M | 33.90M | 22.05% |
| Dec 31, 2014 | 153.77M | 147.20M | 2,239.11% |
| Dec 31, 2013 | 6.57M | -216.99M | -97.06% |
| Dec 31, 2012 | 223.57M | 81.28M | 57.13% |
| Dec 31, 2011 | 142.28M | 54.93M | 62.88% |
| Dec 31, 2010 | 87.36M | 62.04M | 245.03% |
| Dec 31, 2009 | 25.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| H. Lundbeck | 25.52B |
| Genmab | 25.29B |
| Demant | 22.97B |
| GN Store Nord | 16.60B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
Zealand Pharma News
- 7 days ago - Zealand Pharma downgraded to Hold from Buy at Jefferies - TheFly
- 4 weeks ago - Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker - CNBC
- 4 weeks ago - Zealand Pharma downgraded to Hold from Buy at Berenberg - TheFly
- 5 weeks ago - Drugmakers race to find a place in the next wave of obesity drugs - CNBC
- 5 weeks ago - Zealand Pharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot's Side Effects - WSJ
- 6 weeks ago - Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial - Market Watch
- 6 weeks ago - Zealand Pharma shares drop 20% as obesity drug side effects raise concerns - Reuters